Login / Signup
Chao Kong
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Epithelial Mesenchymal Transition
Endoplasmic Reticulum Stress
Diffusion Weighted Imaging
Tyrosine Kinase
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Chao Kong
,
Junyi Pu
,
Qianqian Zhao
,
Weining Weng
,
Linjie Ma
,
Yu Qian
,
Wen-Hao Hu
,
Xun Meng
,
Tao Meng
MTX-13, a novel PTK7-directed antibody-drug conjugate with widened therapeutic index shows sustained tumor regressions for a broader spectrum of PTK7-positive tumors.
Molecular cancer therapeutics
(2023)